News Formal

Verve Pauses Gene-Editing Trial for High Cholesterol Treatment

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 5 sec. here
  • 8 min. at publisher
  • 📊 Quality Score:
  • News: 26%
  • Publisher: 50%

Health News

Verve,Gene-Editing,Trial

Verve, a biotech company, has temporarily halted its gene-editing trial for a high cholesterol treatment. The trial was paused due to safety concerns after a patient experienced an adverse reaction. Verve plans to investigate the cause of the reaction before resuming the trial.

Verve Pauses Gene-Editing Trial for High Cholesterol Treatment EQT Nears $3 Billion Deal for Compliance Risk Firm Avetta Musk’s Starlink Faces Obstruction From Phone Carrier in Italy High-Speed Rollout Xiaomi Jumps as Investors Cheer Early Signs of EV Success Owner of Crypto Platform CoinSwitch Launches Stock Trading App Microsoft-Backed Rubrik Shows $354 Million Loss in IPO Filing The U.S. Fed is failing in four ways: Mohamed A.

El-Erian Remote Working Boom Is Huge for College Towns Like Knoxville Dismal U.S

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

U.S. appeals court temporarily pauses SEC climate disclosure rulesThe 5th U.S. Circuit Court of Appeals granted request for an administrative stay of the rules roughly a week after oil field services companies filed a lawsuit challenging them
Source: globebusiness - 🏆 31. / 66 Read more »